Facilities

TASK has seven dedicated research sites for Phase 1 to Phase 4 research, across various therapeutic areas:

The Netherlands

U-TASK at UMCU (Utrecht Netherlands)

U-TASK is based in Utrecht, The Netherlands in the facilities of University Medical Centre Utrecht (UMCU). U-TASK is a collaboration between TASK and UMCU for Early Clinical Development clinical trials (Phase I, FIH, FIM) with a focus on six Strategic Research Programs:

This collaboration combines the research knowledge of TASK with internationally renowned researchers, in an extensive clinical facility.

Facilities
- Internationally renowned researchers
- Extensive clinical facility
- Certified services
  - Pharmacy
  - Laboratories
  - Biobanking

Phase 1
Phase 2-4

South Africa

TCRC (Cape Town)

TCRC is a registered 24 bed hospital for the conducting of Early Clinical Development (ECD), PK and other in-patient trials. It is one of only two units of its kind in the whole of Africa and competes at an international level. The site has been audited and named a Strategic Site for Early Clinical Development by IQVIA, a large multinational contracts research organization (CRO).

Accreditations and registrations
We’re proud of the accreditations and registrations the unit has received:
- South African Department of Health inspected and registered hospital
- IQVIA Strategic Partner Site for ECD
- Aids Clinical Trial Group (ACTG) approved
- Federal Drug Administration (FDA) and European Medicines Agency (EMA) inspected
- Noted by the Technology Innovation Agency (TIA) of South Africa as a Singular Entity Facility for its Early Bactericidal Activity (EBA) tests
Facilities
TASK’s sites feature a range of facilities including:
- Sample processing facilities with centrifuges and refrigeration
- Central time monitored for IP protocol adherence
- Central temperature monitoring (with Cloud backup and alarm systems)
- Onsite nursing staff equipped and skilled in medical emergency management
- Emergency power infrastructure
- Dedicated participant transport
- CCTV monitored, access-controlled and on site, off street secure parking
- Doctor examination rooms
- Clinical procedures general ward with lung function equipment
- Trial pharmacy for storage & dispensing of Investigational Products
- Dedicated sample processing lab
- In-house pharmacy registered with the South African Pharmacy Council and Department of Health (DOH) – (Brooklyn Chest Site & TCRC)
- Infection controlled participant wards ventilated via negative air pressure and sealed from main centre by automated infection control double doors – (Brooklyn Chest Site & TCRC)
- Outsourced on site specialised catering service ensuring adherence to the nutritional needs of trial participants (TCRC)

South Africa

Phase 2-4 Locations

TASK has the following sites in the Western Cape, South Africa, equipped for the conducting of phase 2 to 4 trials across various therapeutic areas:

TASK Central
TASK Brooklyn Chest
TASK Delft
TASK Eden (Located in George, WC)
Eden Oncology (Located in George, WC)

Facilities
TASK’s sites feature a range of facilities including:
- Sample processing facilities with centrifuges and refrigeration
- Central time monitored for IP protocol adherence
- Central temperature monitoring (with Cloud backup and alarm systems)
- Onsite nursing staff equipped and skilled in medical emergency management
- Emergency power infrastructure
- Dedicated participant transport
- CCTV monitored, access-controlled and on site, off street secure parking
- Doctor examination rooms
- Clinical procedures general ward with lung function equipment
- Trial pharmacy for storage & dispensing of Investigational Products
- Dedicated sample processing lab
- In-house pharmacy registered with the South African Pharmacy Council and Department of Health (DOH) – (Brooklyn Chest Site & TCRC)
- Infection controlled participant wards ventilated via negative air pressure and sealed from main centre by automated infection control double doors – (Brooklyn Chest Site & TCRC)
- Outsourced on site specialised catering service ensuring adherence to the nutritional needs of trial participants (TCRC)